Overview: Legionella Ag TestIntroduction: The Legionella Ag Test detects Legionella antigen to diagnose Legionnaires' disease, causing severe pneumonia or fever, helping guide antibiotic treatment. Affecting 1 in 100,000 people annually, Legionnaires' disease poses diagnostic challenges due to atypical presentation. Following 2023 Centers for Disease Control and Prevention (CDC) guidelines, it uses immunoassay for high sensitivity, supporting bacteriology screening. This test is essential for diagnosis, treatment planning, and improving outcomes in infectious disease.
Other Names: Legionella Antigen Test, Legionnaires' Disease Assay.
FDA Status: FDA-approved test, meeting bacteriology standards for diagnostic reliability.
Historical Milestone: Legionella testing began in the 1970s with research by McDade, who identified the bacterium. Immunoassay advancements in the 1990s by Binax improved detection, surpassing earlier culture methods.
Purpose: Detects Legionella antigen to diagnose Legionnaires' disease, guides antibiotic therapy, and evaluates patients with pneumonia, aiming to reduce severity.
Test Parameters: Legionella antigen presence
Pretest Condition: No special preparation required. Collect urine. Report history of respiratory symptoms.
Specimen: Urine (sterile container, 5-20 mL); 10 mL urine in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 4 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: 1 month
Medical History: Document fever or pneumonia. Include current medications or travel history.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., respiratory failure), and sample collection risks.
Procedural Considerations: Uses immunoassay to detect antigen, requiring labs with analyzers. Results available in 1-2 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample contamination or degradation can affect results. Medications may not affect results but require correlation.
Clinical Significance: Positive antigen confirms Legionnaires' disease, guiding therapy. Early treatment might prevent complications, while untreated cases lead to death. Negative results may require culture.
Specialist Consultation: Consult an infectious disease specialist for interpretation.
Additional Supporting Tests: Chest X-ray, sputum culture, or urinary antigen test to confirm diagnosis.
Test Limitations: Specific to Legionella; correlation with symptoms needed. False negatives possible with early infection.
References: CDC Guidelines, 2023; New England Journal of Medicine, McDade JE, 2022.
